Novel Technologies for In Vivo Imaging

Program Announcements:
PA-06-045: http://grants.nih.gov/grants/guide/pa-files/PA-06-045.html (STTR) and PA-06-046: http://grants.nih.gov/grants/guide/pa-files/PA-06-046.html SBIR) and PA-04-095: http://grants.nih.gov/grants/guide/pa-files/PA-04-095.html (expiration date 11/2/2006)

Contacts:
Guoying Liu, Ph.D.—research in MRI, MRS, and multimodalities
301-594-5220, liug@mail.nih.gov

Keyvan Farahani, Ph.D.—research in image-guided therapy
301-451-2651, farahank@mail.nih.gov

James A. Deye, Ph.D.—research in radiation therapy
301-496-6276, deyej@mail.nih.gov

Houston Baker, Ph.D.—other areas of research
301-594-9117, bakerhou@mail.nih.gov

Three program announcements comprise the CIP initiative Novel Technologies for In Vivo Imaging. Two are open to U.S. small business applicants, PA-06-045 for STTR and PA-06-046 for SBIR. The third, PA-04-095, uses the R21/R33 grant mechanism. It is modeled on the SBIR/STTR Fast Track, but unlike the Fast Track, it is open to all applicants. All three program announcements encourage the development and delivery of imaging tools and related resources to support biomedical imaging for cancer and other diseases. One motivation is to facilitate multidisciplinary development of novel imaging technologies for risk assessment, early detection, screening, diagnosis, and treatment. The program also supports limited evaluation studies that show proof-of-concept and clinical functionality.

Another motivation for these program announcements is shared with the NIH-wide Bioengineering Consortium (BECON) committee’s efforts with the Bioengineering Research Partnership (BRP) and Bioengineering Research Grant (BRG) R01 program announcements. BECON, with CIP participation, seeks to expand acceptance of engineering’s design-driven, problem-solving approaches as a reasonable addition to the hypothesis-driven and mechanistic paradigms already well established in most R01 study sections.